Application of this analysis to a cohort of 52 ER+ breast cancer biopsy samples revealed a significant correlation between GDNF-RGS expression and letrozole resistance, with the highest GDNF-RGS occurring in Luminal B tumors, suggesting a relationship between RET activity and poor breast cancer prognosis. The gene discussed is GDNF; the disease is breast carcinoma.